Cancer Immunotherapy Drug Discovery Outsourcing Market (By Drug type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines, Others; By Cancer type - Target Identification and Validation, Lead Screening and Characterization, Cell Based Assays; By Service type - HealtLung, Breast, Colorectal, Melanoma, Prostate, Head and Neck, Ovarian, Pancreatic) - Global Industry Size, Share, Trends and Forecast 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

The global cancer immunotherapy drug discovery outsourcingmarket is project worth $1.8 Billion in 2026 and the market is projected to showcase 14.0% CAGR during the forecast period. The market is driven by increasing cancer patients and surging awareness about developments and improvement in cancer immunotherapy.

Market Dynamics

Increase in occurrence of cancer disease and increasing mortality associated with cancer are the key reasons for the growth of the cancer immunotherapy drug discovery outsourcing market. Furthermore, supportive government regulation for healthcare sector is optimistically impacting the development of the market and is anticipated to drive the development during the forecast period.

Increasing number of cancer patients across the world drive the demand for better cancer treatment and diagnostics services globally during the forecast period. Also, Pharmaceutical businesses are concentrating on immunotherapies subsequently they are a potential treatment alternative for cancer due to their capability to shrink the risk of post chemotherapy tumor reoccurrence.

Furthermore, favourable tax credit permits pharmaceutical businesses to properly plan their global projects with a reputed CRO, which will help in them in growing their business and avoiding taxation related problems. This factor also contribute in the growth of the market.

Market Insights

The global cancer immunotherapy drug discovery outsourcingmarket is anticipated to account the substantial growth in the coming years, attributed to increasing alertness and awareness about developments in cancer immunotherapy paired with growing investments by pharmaceutical businesses in outsourcing and subcontracting is anticipated to boost in the growth of thecancer immunotherapy drug discovery outsourcing market.

Market Classification

The global cancer immunotherapy drug discovery outsourcing market is segmented into four major segment named drug type, service type, cancer type, and region. On the basis of drug type the cancer immunotherapy drug discovery outsourcing market is segmented intomonoclonal antibodies, immunomodulators, oncolytic viral therapies and cancer vaccines, and others. On the basis of the service type the global cancer immunotherapy drug discovery outsourcing market is segmented into target identification and validation, lead screening and characterization and cell based assays.On the basis of cancer type, the cancer immunotherapy drug discovery outsourcing market is segmented into lung, breast, colorectal, melanoma, prostate, head and neck, ovarian and pancreatic. On the basis of region the global Cancer Immunotherapy Drug Discovery Outsourcing market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Regional Insights

In 2018, North America accounts largest revenue share and the region is anticipated to continue its dominance over the forecast period as the region has domicile of big pharmaceutical giants. Other reason for the growth of the North America cancer immunotherapy drug discovery outsourcing market are high per capita healthcare expenditure, and increasing awareness about the canner treatment and diagnostic system.

Europe is anticipated to be the second fastest-developing market for cancer immunotherapy drug discovery outsourcing. Increased incidence of cancer diseases and occurrence of a huge target population base are the crucial factors growing demand for cancer immunotherapy drug discovery outsourcingin the region.

Report Coverage

Market

Cancer Immunotherapy Drug Discovery OutsourcingMarket

Analysis Period

2016– 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Drug type, Service type, Cancer typeand Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The major players associated with the cancer immunotherapy drug discovery outsourcing market Aquila BioMedical,Crown Bioscience, Inc.,Molecular Imaging, Inc.,Explicyte,Horizon Discovery Group PLC,STC Biologics,Promega Corporation,Personalis, Inc.,HD Biosciences Co.,DiscoverX Corporation,Genscript Biotech Corporation,BPS Bioscience, Inc.,ImmunXperts SA, andCelentyx Ltd.

Market Segmentation

Market ByDrug type

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies and Cancer Vaccines
  • Others

Market ByCancer type

  • Target Identification and Validation
  • Lead Screening and Characterization
  • Cell Based Assays

Market ByService type

  • HealtLung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head and Neck
  • Ovarian
  • Pancreatic

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary